Product NewsDrug Discovery & Development CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development
Turning FDA guidance into lab reality – Accelerating animal-free drug pipelines with organ-on-a-chip technology Jun 23, 2025
